𝔖 Bobbio Scriptorium
✦   LIBER   ✦

S-14-2 - Muscarinic partial agonists in the symptomatic treatment of Alzheimer's Disease

✍ Scribed by R. Kumar; E. Cedar; M. Clark; J. Loudon; J. McCafferty; L. Hammond


Book ID
119177132
Publisher
Elsevier Science
Year
1996
Tongue
English
Weight
147 KB
Volume
6
Category
Article
ISSN
0924-977X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Xanomeline: A selective muscarinic agoni
✍ Frank P. Bymaster; Celia A. Whitesitt; Harlan E. Shannon; Neil DeLapp; John S. W πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 147 KB πŸ‘ 3 views

Xanomeline is a novel muscarinic receptor agonist relatively devoid of parasympathomimetic side effects. Xanomeline had high affinity for muscarinic receptors and much lower affinity for a variety of other neuronal receptors in radioligand binding assays. Functional studies in cell lines transfected